| 000 | 01437 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516020457.0 | ||
| 264 | 0 | _c20110510 | |
| 008 | 201105s 0 0 eng d | ||
| 022 | _a1173-2563 | ||
| 024 | 7 |
_a10.2165/11586700-000000000-00000 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOng, Janus P | |
| 245 | 0 | 0 |
_aOral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study. _h[electronic resource] |
| 260 |
_bClinical drug investigation _c2011 |
||
| 300 |
_a213-20 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aDipeptides _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHepatic Encephalopathy _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLiver Cirrhosis _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 700 | 1 | _aOehler, Gerd | |
| 700 | 1 | _aKrüger-Jansen, Christiane | |
| 700 | 1 | _aLambert-Baumann, Judith | |
| 700 | 1 | _aYounossi, Zobair M | |
| 773 | 0 |
_tClinical drug investigation _gvol. 31 _gno. 4 _gp. 213-20 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2165/11586700-000000000-00000 _zAvailable from publisher's website |
| 999 |
_c20493483 _d20493483 |
||